- The company produced a disappointing Q3, with one-off issues at two customers shaving $1 million off revenue and organic growth slowing down to 15%.
- However, investors should not be too worried about that, as the company keeps adding dozens of new customers each quarter – over 400 in total – and growth will come back.
- In the meantime, acquisitions are leveraged to ramp up sales quickly, building a much more substantial company and thus increasing the wallet spend of customers.
BioLife’s Disappointing Quarter Masks A Much Better Future
November 15th, 2019 · No Comments